A study enrolled 52 PD patients and 87 HCs, measured the CSF concentrations of Ng, and explored the associations between Ng with motor symptoms (evaluated by Hoehn and Yahr scale) as well as cognitive symptoms (evaluated by the Montreal Cognitive Assessment scores) (Bereczki et al., 2017). Here, NRGN is linked to Parkinson disease.